DOI:
10.1055/s-00000167
International Journal of Angiology
LinksClose Window
References
Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E. ; Heart Outcomes Prevention Evaluation 2 Investigators.
Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.
Stroke 2009;
40 (04) 1365-1372
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.